Table 2.
Multivariate linear regression model for the association of lipoprotein(a) and circulating intermediate monocytes
| Parameter | Univariate P value | β | P value |
|---|---|---|---|
| Lp(a) >50 mg/dL | .014 | 0.22 | .044 |
| Smoking | .024 | 0.22 | .029 |
| LDL cholesterol | .053 | 0.18 | .13 |
| Gender | .12 | 0.11 | .28 |
| Age | .98 | 0.10 | .39 |
| Statin dose | .45 | −0.14 | .43 |
| Total model R2 | 0.17 | .018 |
LDL, low-density lipoprotein.
Statin dose: high-dose statin treatment was defined as treatment with atorvastatin with a dosage of at least 40 mg or rosuvastatin at a dosage of at least 10 mg daily.